NRIXNurix Therapeutics, Inc.

$26.68

Who owns NRIX

195 institutions reported holding NRIX for 2026Q1, together 106% of the company, more than the 181 a quarter earlier.

195

Institutions reporting a position · as of 2026Q1 · up from 181 the quarter before

Shares held by institutions
117.0M

Shares held by institutions · 106% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.81B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
32%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
23
New positions
36
Positions exited
29
Added to
68
Reduced
40
Top 10 holdersof the company
55%
Institutional ownership by quarter, 2020Q3 to 2026Q1
QuarterFilersSharesReported value
2026Q1195117.0M$1.81B
2025Q4181113.4M$2.15B
2025Q317284.8M$783M
2025Q216288.3M$1.01B
2025Q116984.6M$1.01B
2024Q417481.1M$1.53B
2024Q317067.9M$1.53B
2024Q217265.0M$1.36B
2024Q113849.1M$721M
2023Q413046.1M$476M
2023Q312844.8M$352M
2023Q212643.6M$436M
2023Q112342.5M$377M
2022Q411842.7M$469M
2022Q311843.1M$561M
2022Q210645.0M$568M
Largest reported holders, 2026Q1
HolderShares% of companyValue
BlackRock Inc.8.9M8.1%$138M
Redmile Group, LLC7.7M7.0%$120M
Vestal Point Capital, LP6.5M5.9%$101M
Deep Track Capital, LP6.3M5.8%$98M
VANGUARD GROUP INC6.3M5.7%$97M
FMR LLC5.5M5.0%$86M
STATE STREET CORP5.1M4.7%$80M
MORGAN STANLEY4.9M4.5%$76M
BAKER BROS. ADVISORS LP4.7M4.2%$72M
GENERAL ATLANTIC, L.P.4.1M3.7%$64M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…